CD99 (also named MIC2, E2 and thymic leukemia antigen) is the founding member of the CD99 family of molecules. The CD99 family contains four members; CD99, CD99L2, XG and the pseudogene CD99L1 (1, 2, 3). Native human CD99 is 32 kDa in size and exists as a type I transmembrane glycoprotein. This is referred to as the long, or type I isoform. It is synthesized as a 185 amino acid (aa) precursor that contains a 22 aa signal sequence, a 100 aa extracellular domain (ECD), a 25 aa transmembrane segment, and a 38 aa cytoplasmic region (4). The ECD contains no identifiable motifs, N‑linked glycosylation sites, or cysteine residues; it does possess sites for O-linked glycosylation. The cytoplasmic region, albeit short, does have signal transduction capability (5). There are apparently multiple isoforms for human CD99. One shows a 16 aa deletion in the ECD (aa 34‑49), a second shows a 38 aa deletion in the cytoplasmic region (aa 122‑159), and a third exhibits a three aa truncation at the C-terminus (6, 7, 8). The best studied isoform shows an Asp‑Gly substitution for the C‑terminal 27 amino acids. This is referred to as the 28 kDa type II isoform (9). The type I and II isoforms have distinctive signal transduction pathways (FAK-src for type I; PI3K plus src-ERK1/2 for type II), and mediate clearly different biological outcomes (5, 9, 10). The two numbered isoforms may or may not co‑exist on the same cells. Peripheral T cells have only the long isoform, while double-positive thymocytes express both isotypes. What is unclear is the monomeric vs. dimeric status of CD99. In mouse, CD99 reportedly forms disulfide-linked homodimers (11). In human, however, CD99 is reportedly monomeric if only a type I isoform, and a covalent heterodimer if co‑expressing type I and II isoforms (12, 13). Cells known to express CD99 include fibroblasts, neutrophils, T cells, double-positive thymocytes, CD34+ stem cells, monocytes and endothelial cells (2, 12, 14, 15). Homophilic interaction between CD99 on the neutrophil and CD99 on the endothelial cell regulates the transendothelial migration of neutrophils during inflammation (16). Human CD99 is only 48% aa identical to mouse CD99 (17).
Human CD99 Biotinylated Antibody
R&D Systems | Catalog # BAF3968
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human
Applications
Validated:
Western Blot
Cited:
Western Blot
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Loading...
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human CD99
Asp23-Asp122
Accession # P14209
Asp23-Asp122
Accession # P14209
Specificity
Detects human CD99 in Western blots. In Western blots, less than 5% cross‑reactivity with recombinant mouse CD99 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Human CD99 Biotinylated Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Human CD99 Fc Chimera (Catalog # 3968-CD)
Sample: Recombinant Human CD99 Fc Chimera (Catalog # 3968-CD)
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: CD99
References
- Wilson, M.D. et al. (2006) Physiol Genomics 27:201.
- Petri, B. and M.G. Bixel (2006) FEBS J. 273:4399.
- Suh, Y.H. et al. (2003) Gene 307:63.
- Gelin, C. et al. (1989) EMBO J. 8:3253.
- Byun, H-J. et al. (2006) J. Biol. Chem. 281:34833.
- GenBank Accession # EAW98698.
- GenBank Accession # EAW98699.
- GenBank Accession # EAW98700.
- Hahn, H-J. et al. (1997) J. Immunol. 159:2250.
- Scotlandi, K. et al. (2007) Oncogene Apr 30; [Epub ahead of print].
- Park, S.H. et al. (2005) Gene 353:177.
- Schenkel, A.R. et al. (2002) Nat. Immunol. 3:143.
- Alberti, I. et al. (2002) FASEB J. 16:1946.
- Imbert, A-M. et al. (2006) Blood 108:2578.
- Dworzak, M.N. et al. (1994) Blood 83:415.
- Lou, O. et al. (2007) J. Immunol. 178:1136
- Shiratori, I. et al. (2004) J. Exp. Med. 199:525.
Alternate Names
CD99, MIC2, pilr-1, PILR-L
Gene Symbol
CD99
UniProt
Additional CD99 Products
Product Documents for Human CD99 Biotinylated Antibody
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human CD99 Biotinylated Antibody
For research use only
Related Research Areas
Citations for Human CD99 Biotinylated Antibody
Customer Reviews for Human CD99 Biotinylated Antibody
There are currently no reviews for this product. Be the first to review Human CD99 Biotinylated Antibody and earn rewards!
Have you used Human CD99 Biotinylated Antibody?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Cellular Response to Hypoxia Protocols
- R&D Systems Quality Control Western Blot Protocol
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars